Turbo Cancers and mRNA Vaccines: Examining the 2026 Evidence and Senate Testimony

By Editorial Team -
Summary: Emerging studies and Senate testimony have raised questions about possible links between mRNA vaccination, spike protein biology, and aggressive cancer progression. However, major health agencies continue to state that current evidence does not establish a causal relationship, highlighting the need for further independent research.

The medical community is currently engaged in a rigorous debate regarding a phenomenon colloquially termed "turbo cancer"—a clinical shorthand for malignancies that appear suddenly, grow with unexpected speed, and present at advanced stages in younger populations. While mainstream health organizations often classify these reports as unsubstantiated, a series of 2025 and 2026 studies, along with high-level Senate testimony, have brought new evidence to the forefront regarding the potential oncogenic risks of COVID-19 mRNA vaccine platforms.

Editor's note: The term "turbo cancer" is not a recognized medical diagnosis and that the proposed causal links remain disputed within the scientific community.


The 2026 Senate Hearing: Expert Testimony

On June 3, 2026, the Senate Permanent Subcommittee on Investigations held a hearing to address rising concerns about vaccine safety. Key testimonies included:

  • Dr. Angus Dalgleish — Professor Emeritus of Oncology at the University of London stated that he has "no doubt" that mRNA technology played a significant role in the development of unexpected cancers observed in some patients.
  • Dr. Wafik El-Deiry — Director of Brown University's Legorreta Cancer Center testified that the SARS-CoV-2 spike protein, produced following infection and vaccination, may affect pathways involved in cancer suppression.
  • Dr. Aseem Malhotra — British cardiologist and public health advocate warned that emerging evidence warrants further investigation into potential long-term cancer and cardiovascular risks.

References:


Systematic Reviews and Large-Scale Population Data

Recent peer-reviewed research has shifted discussion from isolated case reports toward broader population-level analyses.

  • 2026 Systematic Review: A peer-reviewed paper published in Oncotarget has pulled these fragmented observations into a single, systematic analysis. The study is authored by senior cancer researchers Charlotte Kuperwasser and Wafik El-Deiry — both respected figures in cancer biology, and both members of the Covid-19 vaccine workgroup advising the CDC’s Advisory Committee on Immunisation Practices. Researchers Charlotte Kuperwasser and Wafik El-Deiry published a review in Oncotarget examining more than 300 published cancer cases reported after COVID-19 vaccination across multiple countries.
  • South Korean Population Study: A large-scale cohort study involving approximately 8.4 million adults reported statistically significant associations between vaccination status and incidence of several cancer types, including prostate cancer.
  • Italian Population Study: An observational analysis of nearly 296,000 individuals followed for approximately 30 months reported increases in cancer incidence that investigators concluded warranted additional study.
Reference:
Oncotarget Journal

Genomic Integration and Proposed Molecular Mechanisms

One of the most significant developments discussed by proponents of the turbo cancer hypothesis was a late-2025 case report describing evidence of vaccine-derived genetic sequences detected within tumor tissue from a 31-year-old woman diagnosed with aggressive stage IV bladder cancer.

Several biological pathways have been proposed as possible mechanisms:

  1. Metabolic Reprogramming
    The spike protein may contribute to mitochondrial dysfunction, potentially promoting a metabolic state resembling the Warburg effect that favors rapid tumor growth.
  2. P53 Suppression
    Disruption of the p53 tumor suppressor pathway could theoretically impair apoptosis and permit survival of genetically abnormal cells.
  3. Immune Dysregulation
    Repeated mRNA exposure has been associated with increased IgG4 antibody responses, raising questions regarding long-term immune surveillance against malignant cells.
  4. Transcriptomic Dysregulation
    RNA sequencing studies have reported alterations in the expression of numerous genes following vaccination, although the clinical significance remains under investigation.
Reference:

Clinical Observations of "Turbo Cancer"

Clinicians reporting these cases have described cancers that appear to deviate from traditional oncologic patterns. Reported observations include:

  • Stage III and Stage IV cancers appearing in previously healthy individuals in their 20s and 30s.
  • Rapid progression shortly after diagnosis.
  • Unexpected relapses among patients previously considered stable or in remission.

The cancer types most frequently cited in these reports include:

  • Lymphoma
  • Glioblastoma
  • Triple-negative breast cancer
  • Colorectal cancer
  • Lung cancer
Reference:

Mainstream Medical Perspective

Despite these reports, major health organizations maintain that available evidence does not establish a causal relationship between COVID-19 vaccination and cancer development.

The National Cancer Institute (NCI) states that there is currently no evidence that COVID-19 vaccines cause cancer or increase cancer recurrence. Likewise, many oncologists emphasize that temporal association alone does not demonstrate causation.

Critics of the turbo cancer hypothesis note that:

  • Many cancers develop over years before diagnosis.
  • Rates of early-onset cancers were increasing before the COVID-19 pandemic.
  • Obesity, sedentary lifestyle, environmental exposures, and dietary factors remain established contributors to cancer risk.

Reference:
National Cancer Institute – COVID-19 Vaccines and Cancer


Conclusion and Future Outlook

The debate regarding turbo cancers and mRNA vaccines remains unresolved. Researchers and clinicians including Dr. Wafik El-Deiry, Dr. William Makis, and Dr. Paul Marik have called for additional investigation into potential molecular mechanisms and long-term surveillance of vaccinated populations.

Advocates argue that systematic genomic monitoring, transparent adverse-event reporting, and independent research are needed to clarify whether rare cancer events are causally linked to vaccination or represent coincidental occurrences within large populations.

Some clinicians have proposed supportive approaches involving compounds such as nattokinase, bromelain, and curcumin for individuals concerned about persistent spike protein; however, these interventions remain investigational and have not been established as treatments for vaccine-related cancer risk.

Comments

Post a Comment

Popular posts from this blog

Dr Peter McCullough: How to Detox Spike Protein from Body (2026 Update)

By Editorial Team -
Image
Base Spike Detox According to Dr Peter McCullough (in a X/Twitter post): Base Spike Detox is what I am currently using in my practice for those who have had COVID-19 multiple times, one or more of the COVID-19 vaccines, or both and believe persistent SARS-CoV-2 Spike protein could be causing problems in their body.  I have arrived, based on the emerging scientific literature (1) and my clinical observation, that three OTC products are essential as a triple base combination: Nattokinase 2000 FU (100 mg) twice a day  — take on an empty stomach Bromelain 500 mg once a day  — take on an empty stomach Nano/Liposomal Curcumin 500 mg twice a day  — take with food How long should I take this? Dr. McCullough recommends a minimum of 3 months , with many patients requiring 6–12 months or longer. Progress can be tracked via a spike protein antibody test (available through Labcorp in m...
Read more

Dr Peter McCullough: How to Measure Your Spike Protein Antibody (2026)

By Editorial Team -
Image
Dr. McCullough explained (1) that the spike protein is an engineered, synthetic molecule roughly 1,200 amino acids long and resistant to degradation by the body’s normal proteases. He described how the protein was modified in laboratory settings (notably at the Wuhan Institute of Virology) to tightly bind to the ACE2 receptor, which is found throughout the body—in the lungs, heart, endothelium, kidneys, and brain. Because this receptor regulates angiotensin metabolism, older individuals with fewer ACE2 sites catabolize the spike less efficiently, leading to worse outcomes. Whether introduced by infection or by genetic‑code‑based vaccines, McCullough asserted, the persistent spike damages tissues directly and through chronic inflammation, micro‑clotting, and autoimmune cross‑reactivity. He cited more than 300 papers documenting spike deposits in the heart, brain, and vascular tissue, relating these findings to post‑vaccine myocarditis, strokes, and clotting disorders. A chief diagnostic...
Read more

How to Remove Spike Protein from Body: FLCCC I-Recover Protocol

By Editorial Team -
Image
Can you remove spike proteins from your body? Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC*, which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a private tele-health practice specializing in the treatment of COVID-19, so-called "long-COVID" and post-vaccine syndrome. *The FLCCC Alliance is now the  Independent Medical Alliance Note that there are significant overlaps between the symptoms and features of long COVID/long-hauler syndrome and post-vaccine syndrome. However, a number of clinical features appear to be characteristic of post-vaccine syndrome; most notably, severe neurological symptoms appear to be more common following vaccination. To c...
Read more

McCairn–Edogawa Protocol: Viral Long COVID Cure from Japan?

By Editorial Team -
Image
The McCairn Protocol (Edogawa–McCairn Protocol): Overview and Mechanistic Rationale The McCairn Protocol (also referred to as the Edogawa–McCairn Protocol ) is an experimental, two-phase treatment approach promoted by Kevin McCairn in collaboration with Edogawa Hospital. It is primarily proposed for individuals with Long COVID and post-mRNA vaccine–associated syndromes , targeting hypothesized drivers such as persistent spike protein, amyloid-like fibrin microclots, autoantibodies, chronic inflammation, and associated vascular or neurological dysfunction. Phase 1: Double Filtration Plasmapheresis (DFPP) / Plasma Adsorption (“Cleansing”) Double Filtration Plasmapheresis (DFPP) is a specialized form of therapeutic apheresis currently used in parts of Asia, including Japan, for selected autoimmune, neurological, and metabolic conditions. Procedure Blood is withdrawn, often via a large-bore catheter (e.g., internal jugular access). It is passed through a dual-filtration syste...
Read more

Dr. Peter McCullough's Spike Protein Detox Protocol: Base Spike Detox Explained

By Editorial Team -
Image
A clinician-developed regimen of nattokinase, bromelain, and curcumin for clearing persistent SARS-CoV-2 spike protein — with dosing, safety guidance, monitoring, and full FAQ.   Editorial Team   |  Originally published March 2023  |  Last updated December 30, 2025  |  Reviewed against published literature and Dr. McCullough's 2025 clinical updates ⚠️ Medical Disclaimer — Please Read First This article is for  educational purposes only  and does not constitute medical advice, diagnosis, or treatment. The Base Spike Detox protocol involves supplements with significant anticoagulant activity. Always consult a licensed physician before starting , especially if you are taking blood thinners, are pregnant or breastfeeding, have a bleeding disorder, or are treating a child. For a virtual consultation with a physician familiar with this protocol,...
Read more

Find a Doctor to prescribe Hydroxychloroquine, Ivermectin and Early Outpatient Treatments (2025)

By Editorial Team -
Image
Treatment should start based on clinical suspicion as soon as possible, preferably within the first 3 days of symptoms. Perform PCR testing, but do not withhold treatment pending results. 'Early' treatment will make significant difference in outcome as opposed to late treatment.  Related: How can I get Ivermectin? See the directory of professionals in US below. Directory of Doctors (by State) Prescribing Effective Outpatient COVID-19 Therapy USA ​ MULTIPLE STATES (Telemedicine or online consultation) The Wellness Company ( twc.health ) Medical Specialty: Family Medicine, Functional Medicine Supported Protocols: I-PREVENT (COVID Protection), I-CARE (Early at-home treatment), I-RECOVER (Long COVID and Post-Vaccine treatment) Dr. Miguel Antonatos (IVM) (855) 767-8559  https://text2md.com (States: AL, AZ, CO, FL, GA, IA, ID, IL, KS, KY, MD, ME, MI, MN, MS, ND, NE, NJ, NV, OK, SC, SD, TN, UT, VT, WA, WI, WV) ...
Read more

Dr Peter McCullough: Povidone Iodine, Oral and Nasal Hygiene (2026)

By Editorial Team -
Image
Dr. Peter McCullough is an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas, USA. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough Protocol 2022 Update: Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial ( JAMA 2025 ) Everyone is familiar with nasal and oral swab testing for COVID-19. It should be obvious the virus is replicating in the nose, and with Omicron, the speed of replication has become much greater than the prior strains of the virus. Thus, there is a wonderful opportunity to reduce viral replication, in fa...
Read more

Ebola Outbreak in Congo 2026: 87 Dead, No Vaccine for New Strain as Virus Crosses into Uganda

By Editorial Team -
Image
A fast-spreading Ebola outbreak in the DRC's Ituri province has killed at least 87 people across 246 suspected cases — and experts warn the Bundibugyo strain driving it has no approved vaccine. By One Day MD Editorial Team · Updated May 17, 2026 · 6 min read 87+ Deaths confirmed 246 Suspected cases 13 Lab-confirmed cases 0 Approved vaccines A deadly Ebola outbreak has been confirmed in the Democratic Republic of Congo (DRC), health authorities announced on May 15, 2026 — and it is already spreading beyond the country's borders. At least 87 people have died and 246 suspected cases have been recorded in Ituri province, eastern DRC, making this the country's 17th Ebola outbreak since the virus was first identified there in 1976. What makes this outbreak uniquely alarming is the strain involved. Unlike the majority of Congo's previous outbreaks — which were caused by the well...
Read more

FLCCC I-Recover Protocol: Post Vaccine Treatment Protocol (2025)

By Editorial Team -
Image
Over the last three years, the COVID-19 pandemic has transformed almost every aspect of our lives before we've had time to stop and question it. Although no official definition exists for post-COVID-vaccine syndrome, a temporal correlation between a patient receiving a COVID-19 vaccine and beginning or worsening of clinical manifestations is sufficient to diagnose as a COVID-19 vaccine-induced injury, when the symptoms are unexplained by other concurrent causes. Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC ( The FLCCC Alliance is now the Independent Medical Alliance ), which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a priva...
Read more

Front Line Doctors Ivermectin Protocol for Prevention and Treatment of COVID-19 (2025)

By Editorial Team -
Image
The Front Line COVID-19 Critical Care (FLCCC*) Alliance was initially formed as a working group during the early COVID-19 pandemic days in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive death rate.  *The FLCCC Alliance is now the  Independent Medical Alliance Based on rapidly emerging clinical trials evidence, the FLCCC team has developed the   I-MASK+ protocol   ( is now divided into I-Prevent and I-Care protocols ) for prophylaxis and at home treatment of early stage COVID-19. Quercetin, zinc and a number of nutrients and drugs are part of this protocol, not only for critical care but also for prophylaxis and mild disease being treated at home. This article, we will dive deeper to provide the scientific background, related references and rationale of the FLCCC protocols. December 2025 Update: The Stratus Variant (XFG): Symptoms, Global Spread, and Impact in Late 2025 FLCCC ( ...
Read more

Labels

Show more